Lanthier P L, Morgan M Y, Ballantyne J
J Laryngol Otol. 1984 Apr;98(4):399-404. doi: 10.1017/s0022215100146808.
Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus suggesting that this drug may produce a reversible ototoxicity.
三名接受溴隐亭治疗慢性肝性脑病的患者出现双侧感音神经性听力损失的听力测定证据。听力测定显示，当降低溴隐亭剂量时，这三名患者的听力均有所改善，因此提示该药物可能会产生可逆性耳毒性。
